Covered recipient · General Payments record
JESSICA P JAMES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$278.42
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.46 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $34.45 | 2 |
| Novo Nordisk AS | $32.53 | 2 |
| ABBVIE INC. | $21.59 | 1 |
| Atland Pharmaceuticals, LLC | $19.25 | 1 |
| Neurocrine BioSciences, Inc. | $16.39 | 1 |
| Acerta Pharma LLC | $14.96 | 1 |
| DEXCOM, INC. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.59 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107394183 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.96 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105653020 | CMS |
| Atland Pharmaceuticals, LLC | $19.25 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067526745 | CMS |
| Dexcom, Inc. | $14.29 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153366837 | CMS |
| Janssen Pharmaceuticals, Inc | $17.05 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077905729 | CMS |
| Janssen Pharmaceuticals, Inc | $17.40 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077905727 | CMS |
| Neurocrine Biosciences, Inc. | $16.39 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150997867 | CMS |
| Novo Nordisk Inc | $15.67 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514621 | CMS |
| Novo Nordisk Inc | $16.86 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100227766 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.